XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 2,668,000 $ 1,000
Accounts receivable, net 128,000
Current portion of notes receivable 142,000 203,000
Prepaid expenses and other current assets 365,000
Total current assets 3,175,000 332,000
Property, plant and equipment, net 282,000 287,000
Notes receivable 59,000
Goodwill 25,093,000 25,093,000
Other intangible assets, net 18,086,000 18,921,000
Total assets 46,695,000 44,633,000
Current liabilities:    
Accounts payable 1,001,000 832,000
Accrued expenses and deferred revenue 102,000 230,000
Current portion note payable, related party 35,000 12,074,000
Total current liabilities 1,138,000 13,136,000
Long-term portion note payable, related party 7,971,000
Deferred tax liability, net 3,235,000 3,235,000
Total liabilities 12,344,000 16,371,000
Commitments and contingencies (Note 11)
Stockholders’ equity    
Preferred stock, $.001 par value; 100,000,000 shares authorized, 60,496,041 shares issued and outstanding (60,496,041 on December 31, 2023); Liquidation value $0.001 per share, $60,000 aggregate. $60,000 on December 31, 2023). 60,000 60,000
Common stock, $.001 par value; 4,000,000,000 shares authorized, 11,503,955 shares issued and outstanding (10,000,000 on December 31, 2023) 11,000 10,000
Additional paid-in capital 41,838,000 38,113,000
Accumulated deficit (10,561,000) (12,961,000)
Total stockholders’ equity of the Company 31,348,000 25,222,000
Non-controlling interest in subsidiaries 3,003,000 3,040,000
Total stockholders’ equity 34,351,000 28,262,000
Total liabilities and stockholders’ equity $ 46,695,000 $ 44,633,000